Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Quantum Leap Healthcare Collaborative sponsors innovative adaptive platform trials like I-SPY 2 to rapidly evaluate new therapies for breast cancer using biomarker-driven approaches. The organization has enabled identification of promising treatments tailored to specific patient subgroups based on molecular characteristics. The RECAST DCIS study aims to redefine management of ductal carcinoma in situ with alternative strategies beyond standard care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Quantum Leap Healthcare Collaborative.